Cibinqo (abrocitinib)
pCPA File Number:
21987
Negotiation Status:
Under consideration for negotiation
Indication(s):
moderate to severe atopic dermatitis
Sponsor/Manufacturer:
Pfizer Canada ULC
CADTH Project Number:
SR0686
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable